Biohaven Ltd [NYSE: BHVN] closed the trading session at $15.6 on 2025-07-30. The day’s price range saw the stock hit a low of $13.4, while the highest price level was $16.0.
The stocks have a year to date performance of -62.15 percent and weekly performance of 13.54 percent. The stock has been moved at -59.34 percent over the last six months. The stock has performed 10.56 percent around the most recent 30 days and changed -28.70 percent over the most recent 3-months.
If compared to the average trading volume of 2.00M shares, BHVN reached to a volume of 7153290 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Biohaven Ltd [BHVN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BHVN shares is $54.21 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BHVN stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Biohaven Ltd shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on May 19, 2025. While these analysts kept the previous recommendation, Deutsche Bank raised their target price to Buy. The new note on the price target was released on February 11, 2025, representing the official price target for Biohaven Ltd stock. Previously, the target price had yet another raise to $57, while Jefferies analysts kept a Buy rating on BHVN stock.
The Price to Book ratio for the last quarter was 6.14, with the Price to Cash per share for the same quarter was set at 3.17.
BHVN stock trade performance evaluation
Biohaven Ltd [BHVN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.54. With this latest performance, BHVN shares gained by 10.56% in over the last four-week period, additionally sinking by -59.34% over the last 6 months – not to mention a drop of -58.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHVN stock in for the last two-week period is set at 57.99, with the RSI for the last a single of trading hit 1.02, and the three-weeks RSI is set at 1.02 for Biohaven Ltd [BHVN]. The present Moving Average for the last 50 days of trading for this stock 14.79, while it was recorded at 13.73 for the last single week of trading, and 30.76 for the last 200 days.
Biohaven Ltd (BHVN) Capital Structure & Debt Analysis
According to recent financial data for Biohaven Ltd. ( BHVN), the Return on Equity (ROE) stands at -316.82%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -202.53%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Biohaven Ltd’s Return on Invested Capital (ROIC) is -306.10%, showcasing its effectiveness in deploying capital for earnings.
Biohaven Ltd (BHVN) Efficiency & Liquidity Metrics
Based on Biohaven Ltd’s (BHVN) latest financial statements, the Debt-to-Equity Ratio is 0.14%, indicating its reliance on debt financing relative to shareholder equity.
Biohaven Ltd (BHVN) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Biohaven Ltd. (BHVN) effectively leverages its workforce, generating an average of -$3471093.75 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.33% and a Quick Ratio of 2.33%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Biohaven Ltd [BHVN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHVN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Biohaven Ltd go to 18.05%.
Biohaven Ltd [BHVN]: Institutional Ownership
There are presently around $90.69%, or 103.01% of BHVN stock, in the hands of institutional investors. The top three institutional holders of BHVN stocks are: VANGUARD GROUP INC with ownership of 7.27 million shares, which is approximately 8.2855%. STIFEL FINANCIAL CORP, holding 6.48 million shares of the stock with an approximate value of $$224.94 million in BHVN stocks shares; and STIFEL FINANCIAL CORP, currently with $$214.15 million in BHVN stock with ownership which is approximately 7.0298%.
